Sean E. Aeder

Array ( [id] => 5648956 [patent_doc_number] => 20060134688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Genes overexpressed in prostate disorders as diagnostic and therapeutic targets' [patent_app_type] => utility [patent_app_number] => 11/353422 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17739 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134688.pdf [firstpage_image] =>[orig_patent_app_number] => 11353422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7965169 [patent_doc_number] => 07939254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Breast cancer related gene ZNFN3A1' [patent_app_type] => utility [patent_app_number] => 11/817303 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15546 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939254.pdf [firstpage_image] =>[orig_patent_app_number] => 11817303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564649 [patent_doc_number] => 20090137502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/883222 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10745 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137502.pdf [firstpage_image] =>[orig_patent_app_number] => 11883222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367696 [patent_doc_number] => 20090305255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => ' Substrate Protein for M-Phase Kinase and use Thereof' [patent_app_type] => utility [patent_app_number] => 12/223482 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18244 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305255.pdf [firstpage_image] =>[orig_patent_app_number] => 12223482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666999 [patent_doc_number] => 20060172349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'LUCA2 and antibodies that bind thereto' [patent_app_type] => utility [patent_app_number] => 11/344814 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24285 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172349.pdf [firstpage_image] =>[orig_patent_app_number] => 11344814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857880 [patent_doc_number] => 20060228347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Antitumor agent and dnase' [patent_app_type] => utility [patent_app_number] => 11/337544 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13842 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228347.pdf [firstpage_image] =>[orig_patent_app_number] => 11337544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727939 [patent_doc_number] => 20080207483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods and compositions for diagnosis and therapy of cancer based on hyper-mutated tumor genes' [patent_app_type] => utility [patent_app_number] => 11/333076 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25728 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207483.pdf [firstpage_image] =>[orig_patent_app_number] => 11333076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4468662 [patent_doc_number] => 07943306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Gene expression signature for prediction of human cancer progression' [patent_app_type] => utility [patent_app_number] => 11/332547 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36371 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943306.pdf [firstpage_image] =>[orig_patent_app_number] => 11332547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334123 [patent_doc_number] => 07507534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Rapid efficacy assessment method for lung cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/306532 [patent_app_country] => US [patent_app_date] => 2005-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6206 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 374 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507534.pdf [firstpage_image] =>[orig_patent_app_number] => 11306532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784312 [patent_doc_number] => 20060204497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63' [patent_app_type] => utility [patent_app_number] => 11/321624 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 36384 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204497.pdf [firstpage_image] =>[orig_patent_app_number] => 11321624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204936 [patent_doc_number] => 20070026417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Devices and methods for enrichment and alteration of circulating tumor cells and other particles' [patent_app_type] => utility [patent_app_number] => 11/323962 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 108 [patent_no_of_words] => 28631 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026417.pdf [firstpage_image] =>[orig_patent_app_number] => 11323962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533049 [patent_doc_number] => 20090232837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'ANTI TUMORAL IMMUNOGENIC PEPTIDES AND VACCINE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/722863 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5183 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232837.pdf [firstpage_image] =>[orig_patent_app_number] => 11722863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630977 [patent_doc_number] => 20060147445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 11/318969 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23645 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147445.pdf [firstpage_image] =>[orig_patent_app_number] => 11318969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866022 [patent_doc_number] => 20060100153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'HSulf-1 nucleic acids, polypeptides and methods of using' [patent_app_type] => utility [patent_app_number] => 11/316132 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25742 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100153.pdf [firstpage_image] =>[orig_patent_app_number] => 11316132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742794 [patent_doc_number] => 20060088519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Malignant tumor-inhibiting preparation comprising Des A fibrin' [patent_app_type] => utility [patent_app_number] => 11/314443 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6243 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088519.pdf [firstpage_image] =>[orig_patent_app_number] => 11314443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697827 [patent_doc_number] => 20080220011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Use of Flagellin in Tumor Immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/793156 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18541 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220011.pdf [firstpage_image] =>[orig_patent_app_number] => 11793156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140464 [patent_doc_number] => 08580925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Method for examining carcinoma and adenoma' [patent_app_type] => utility [patent_app_number] => 11/795328 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3236 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11795328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514748 [patent_doc_number] => 20090215055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Genetic Brain Tumor Markers' [patent_app_type] => utility [patent_app_number] => 12/097385 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23886 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215055.pdf [firstpage_image] =>[orig_patent_app_number] => 12097385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865042 [patent_doc_number] => 20060099172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of prophylaxis and treatment of avian influenza' [patent_app_type] => utility [patent_app_number] => 11/292662 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3073 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099172.pdf [firstpage_image] =>[orig_patent_app_number] => 11292662 [rel_patent_id] =>[rel_patent_doc_number] =>)